Dosidal · Belgium

Glazidim 2 g

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:127312-01 (version 1)
Levelpresentation
Pack codebe-cnk (Belgian national): 0869701
Identifiersbe-cti-extended: 127312-01
be-cnk: 0869701
be-cnk: 0708040
be-authorisation: BE127312
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: REVOKED
ampp_status: REVOKED
commercialised_now: False
lifecycle: history
period_from: 2019-07-12
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM127312-00
atc: J01DD02
authorisation_number: BE127312
cti_extended: 127312-01
form: Powder for solution for infusion
holder: GlaxoSmithKline Pharmaceuticals
medicine_type: ALLOPATHIC
name: Glazidim 2 g
pack: 2000 mg
parallel_circuit: 0
parallel_import: False
substances: substance: Ceftazidime Pentahydrate
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codecnk_hospital: 0708040
cnk_public: 0869701
fmd_in_scope: True
note: no FMD product code in SAM for this pack: the maker's GTIN is not published
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006
class: prescription
delivery_modus: M1
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
wwwhdorbsXTp2cg6_5vDdAXdyi82i3jT7Mfikk_jOMAsUUzn4kGF0bmaRmNnls-9trzep64eOnYOVr7Lll3DJQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal